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Cancer-Related Mortality in People
With Mental Illness
Stephen Kisely, MD, PhD; Elizabeth Crowe, MB, ChB; David Lawrence, PhD
Context:There is a 30%higher case fatality rate fromcan-
cer in psychiatric patients even though their incidence of
cancer is no greater than in the general population. The
reasons are unclear, but if increased cancermortality were
due to lifestyle only, cancer incidence should be similarly
increased. Other hypotheses include delays in presenta-
tion, leading to more advanced staging at diagnosis, and
difficulties in treatment access following diagnosis.
Objective: To assess why psychiatric patients are no
more likely than the general population to develop can-
cer but are more likely to die of it.
Design, Setting, and Patients: A population-based
record-linkage analysis comparedpsychiatric patientswith
the Western Australian population, using an inception
cohort to calculate rates and hazard ratios. Mental health
records were linked with cancer registrations and death
records from January 1, 1988, to December 31, 2007, in
Western Australia.
MainOutcomeMeasures:Metastases, incidence, mor-
tality, and access to cancer interventions.
Results:There were 6586 new cancers in psychiatric pa-
tients. Cancer incidence was lower in psychiatric pa-
tients than in the general population in both males (rate
ratio=0.86; 95% CI, 0.82-0.90) and females (rate ra-
tio=0.92; 95% CI, 0.88-0.96), although mortality was
higher (males: rate ratio=1.52; 95% CI, 1.45-1.60; fe-
males: rate ratio=1.29; 95% CI, 1.22-1.36). The propor-
tion of cancer with metastases at presentation was sig-
nificantly higher in psychiatric patients (7.1%; 95% CI,
6.5%-7.8%) than in the general population (6.1%; 95%
CI, 6.0%-6.2%). Psychiatric patients had a reduced like-
lihood of surgery (hazard ratio=0.81; 95% CI, 0.76-
0.86), especially resection of colorectal, breast, and cer-
vical cancers. They also received significantly less
radiotherapy for breast, colorectal, and uterine cancers
and fewer chemotherapy sessions.
Conclusions: Although incidence is no higher than in
the general population, psychiatric patients aremore likely
to have metastases at diagnosis and less likely to receive
specialized interventions. This may explain their greater
case fatality and highlights the need for improved can-
cer screening and detection.
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M ORTALITY RATES IN PSY-chiatric patients aremuch greater than inthe general popula-tion,1-17 includingNor-
dic countries where longstanding egali-
tarian health andwelfare policiesmight be
expected to facilitate treatment ac-
cess.1,6,8,9,13 Chronic physical disorders such
as cardiovascular disease and cancer are
the main cause,8,10-12 accounting for 10
times the absolute numbers of suicide in
one study but receiving far less atten-
tion.11,18 In cancer, overall mortality is
higher in psychiatric patients, even though
the incidence is similar to that in the gen-
eral population.10,14,15,17 The disparity be-
tween incidence and mortality is most
marked for several common sites such as
prostate and colorectal cancers. Possible
explanations might be delayed diagnosis
or lack of access to screening, leading to
more advanced staging at diagnosis, and
reduced access to or use of appropriate
treatments after diagnosis.
Cancer survival is dependent on both
early diagnosis and access to effective
therapies. Certain populations, includ-
ing those of lower socioeconomic status,
immigrants, thosewith poor literacy skills,
and those living in rural areas, may not
have easy access to screening or diag-
nostic services and therefore may be
more vulnerable to morbidity and mor-
tality associated with cancer. This in-
cludes fecal occult blood testing, endos-
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copy, colonoscopy, and sigmoidoscopy.19,20 Further
inequities have been demonstrated for treatment ser-
vices. Individuals with low income, for example, aremore
likely to receive emergency, as opposed to elective, treat-
ment of chronic diseases16 and less likely to receive spe-
cialist procedures such as palliative radiotherapy.21
There has been less work on the effect of psychiatric
illness on access to cancer care.22 People with severemen-
tal illness, including depression, are less likely to re-
ceive routine cancer screening,23,24 but there is little in-
formation on access to specialist services following
diagnosis.25 If peoplewith psychiatric illness are less likely
to have screening, this may result in more advanced dis-
ease at presentation.
This study investigated to what extent the increased
mortality from cancer in psychiatric patients was asso-
ciated with later presentation, as marked by advanced
disease at cancer diagnosis. The study also investigated
whether, once diagnosed, there was equity of access to
surgery, radiotherapy, and chemotherapy, determined
by whether use matched need as implied by incidence
and mortality. We used administrative data from
Western Australia (WA) to measure both incidence
and mortality rates from cancer in a geographically
defined population of people with mental illness and
compared them with those in the general population
of WA, a state of approximately 2 million people
with universal health care and population-wide cover-
age of cancer registration and use of mental health
services.
In Australia, the states fund general and psychiatric
hospitals as well as community mental health services,
while federally fundedMedicare pays for visits to family
physicians and community specialists. Medicare covers
all Australian residents, although copaymentmay be nec-
essary. More affluent individuals may also buy health in-
surance for private-sector treatment.
METHODS
DATA SOURCES
This was a population-based record-linkage analysis of the WA
Data Linkage System. Individual patient records are linked by
probabilistic matching, using the Automatch software package
(Matchware Technologies), as there are no unique identifica-
tionnumbers in the core data sets.Name, residential address, date
of birth, and sex were used in the probabilistic matching, which
is based on estimating the probability that any 2 records repre-
sent the same person (or event) while allowing for the possibil-
ity of errors or changes in the identifying information. We used
the following data sets: theHospitalMorbidityData System, Reg-
istrar General’s Death RegistrationData,Mental Health Informa-
tion System, and WA Cancer Registry (Table 1).
The project identified all psychiatric patients in WA who
presented with cancer. We used the case definition for psychi-
atric disorder validated by the Public Health Agency of Canada
for use in administrative databases.26 This is any contact with
a health service with an International Classification of Diseases,
Ninth Revision (ICD-9) diagnosis of 290-319 or ICD-10 equiva-
lent.We also included postpartummental disorders (ICD-9 code
648.4), suicide, and nonaccidental injury (ICD-9 codes E950-
959) as well as contact with the mental health system not cov-
ered by these ICD-9 chapter 5 diagnoses to ensure compara-
bility with previous work.10,12,14
We restricted the cohort to patients whose first contact with
mental health services occurred between January 1, 1988, and
December 31, 2007. The start of follow-up was the date of each
patient’s first contact withmental health services. Patients were
censored at the occurrence of the event under study or Decem-
ber 31, 2007. We compared their outcomes with those of the
general population through the calculation of age- and sex-
standardized rates, which were then adjusted for confounders
using multivariate analyses (see “Statistical Analysis”). Incep-
tion cohorts have greater validity owing to the inclusion of all
the follow-up time at risk, thereby reducing the risk of survi-
vorship bias.27
We collected basic information on cancer treatment, includ-
ingwhetherchemotherapyor radiotherapywascommencedwithin
90 days of cancer diagnosis, number of chemotherapy or radio-
therapy sessions, and whether the tumor was surgically re-
moved.28,29 In WA, chemotherapy as a day patient is recorded
within theHospitalMorbidityData System.We also collected in-
formation on time from diagnosis to surgery.
DATA QUALITY
Data quality in epidemiological research can be assessed
through the precision of the disease estimate, the control of
confounders, and the degree of selection and information
bias.30 In this study, the precision of the disease estimate was
maximized through the size of the WA Data Linkage System
data set, which covers 2 million residents.31 Selection bias
was minimized through coverage of all public and private
inpatient admissions as well as public outpatient and ambu-
latory care contacts with mental health services across the
state.31 Information bias was reduced through the use of
aliases and phonetic spelling in probabilistic linkage proto-
cols to minimize linkage failures due to name changes and
spelling variants.31 Cross-linkage with the other databases
within the system further aided the identification of identity
errors. Loss to follow-up due to death was reduced by link-
age to mortality data, while loss to follow-up through emi-
gration was minimized by the state’s geographical isolation
and economic growth. This has led to population flow into
Table 1. Western Australian Data Sources
Data Source Data Obtained
Hospital Morbidity
Data System
All inpatients receiving treatment in a public
or private hospital in Western Australia
Mental Health
Information System
All patients who have had contact with
state-run community-based or outpatient
mental health services in Western Australia
or who have been psychiatric inpatients of
any public or private hospital in the state
Western Australian
Cancer Registry
All admissions to public or private hospitals
and nursing homes; pathology reports for
cancer specimens from pathology
laboratories; data on people who die of
cancer or patients with cancer who die of
other diseases, from linkages to mortality
files of the Registrar of Births, Deaths, and
Marriages (see below) as well as hospital
and pathology data
Registrar General’s
Death Registration
Data
All death registrations in Western Australia
including cause
Australian Bureau of
Statistics
Estimated resident population for all of
Western Australia
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rather than out of the state.31 Checks of data integrity
include the ratio of the number of new cancer diagnoses reg-
istered to the number of cancer deaths (mortality to inci-
dence ratio).32 If trends in incidence, mortality, and migra-
tion are constant, the ratios should remain steady. All-cancer
mortality to incidence ratios for 2008 were similar for males
and females (0.32 and 0.29, respectively), and mortality to
incidence ratios have been relatively stable in recent years.32
In another example, hospital morbidity data were checked
against 1050 clinical records at 7 hospitals. This found 87%
agreement with the data in the Hospital Morbidity Data Sys-
tem.33 A further study checked the consistency of recording
fixed personal characteristics such as sex across different
data sets for the same person. Sex was consistently recorded
across all records for 98.5% of the study population and date
of birth (to an exact same date) was consistent for 83.3% of
records.10 Lastly, linking different registers covering the
same population increases the chance that variables not
available in one database may be available in another,
thereby maximizing the ability to control for confounders.31
In a study of linked hospital morbidity, mental health, and
mortality data, no record had a missing principal diagnosis.
The least complete sociodemographic variable was still
present in 99.99% of records.33
CLASSIFICATIONS OF MENTAL DISORDERS
AND CANCERS
Among the psychiatric cases, we used a hierarchy of last avail-
able vs earlier diagnoses and inpatient vs outpatient care, re-
flecting increasing data reliability. A principal psychiatric di-
agnosis was assigned to each patient who had contact with
mental health services using the following procedure. The fi-
nal diagnosis in a care episode was taken to allow for revision
of preliminary diagnoses during a period of observation or treat-
ment. Diagnoses prior to 2000weremapped from ICD-9 to ICD-
10. The last occurring psychiatric diagnosis across the epi-
sodes was then assigned as the principal diagnosis according
to a diagnostic hierarchy. If an earlier diagnosis was higher in
the hierarchy than the last recorded diagnosis, the earlier di-
agnosis was taken as the principal diagnosis. The hierarchy gave
precedence to organic and psychotic disorders, allowed for con-
ditions such as substance dependence to be considered as po-
tential comorbidities, and then gave preference to conditions
within chapter 5 in ICD-9, or equivalent. Nonspecific disor-
ders outside chapter 5 in ICD-9, or equivalent, came last.
Preference was given to diagnoses made in inpatient treat-
ment units over diagnoses from outpatient clinics or psychi-
atric residential units. Themost recent inpatient diagnosis took
precedence over the most recent outpatient diagnosis even if
the admission predated any outpatient contact. These proce-
dures were designed to allow more specific psychiatric diag-
noses to take precedence over less specific diagnoses and so
that an underlying condition was favored rather than a non-
specific symptom or event. In practice, more than 75% of pa-
tients had only 1 diagnosis within their entire history of con-
tacts with the Mental Health Information System, so the
hierarchy was needed to make a classification decision about
only a small number of complex cases.
Cancers were classified using the International Classifica-
tion ofDiseases forOncology classification of diseases at the 3-digit
level. This follows the same system used for classifying can-
cers by the WA Cancer Registry. The specific sites selected for
further analysis were the most frequent cancers in males and
females.
STATISTICAL ANALYSIS
We initially calculated the age- and sex-standardized rates per
100 000 person-years for mortality and cancer incidence, in-
cluding metastases at diagnosis, for anyone meeting the Pub-
lic Health Agency of Canada case definition of psychiatric dis-
order.26 In the case ofmortality, the primary outcomewas death
from all causes (all-causemortality) to take into account deaths
occurring as a complication of cancer, such as pneumonia in
the context of lung cancer.We also undertook sensitivity analy-
ses looking at patients for whom cancer was coded as the pri-
mary cause (cancer mortality).
We used direct standardization, the standard weights being
taken from the average population distribution ofWA from Janu-
ary 1, 1988, to December 31, 2007. Direct standardization has
several advantages. These include ease of interpretation, re-
producibility given access to the standardizedweights, and com-
parability of rates across studies and across groups within the
same study.34 Direct standardization therefore allowed com-
parisons ofmortality and cancer incidence given that each group
was adjusted to the same standard. Recognizing that direct stan-
dardization can potentially becomeunstablewhenworkingwith
very small cell sizes, we took the precaution of repeating the
analysis using indirect standardization.
Patients were included in the study if their first contact with
mental health serviceswas between January 1, 1988, andDecem-
ber 31, 2007. The period at risk began at the time of this initial
contact. Patients were censored at death or December 31, 2007.
Rates of cancer incidence, metastases, andmortality for the
nonpsychiatric population were calculated in the same way,
using the file of all cancer registrations from January 1, 1988,
to December 31, 2007. Denominators were taken from esti-
mated resident population data.
Rate ratios (RRs) were then calculated to compare the age-
and sex-standardized rates for patients with mental health ser-
vices contact prior to cancer diagnosis vs those in the general
population who did not have psychiatric contact. Rates were
also calculated for each cancer site, so a cancer diagnosis at one
site did not censor the time at risk for any other site. In addi-
tion, we calculated RRs for each psychiatric diagnosis and for
cases that had ever occurred in inpatients.
Cox proportional hazards regression was used to examine
risk factors for cancer among psychiatric patients. These were
expressed as hazard ratios (HRs), with risk periods being cal-
culated in the samemanner as for the analysis of rates. Factors
in themodelwere principal psychiatric diagnosis, age, sex, type
of care received, cumulative length of stay in inpatient care, and
socioeconomic status.As inpreviouswork,14 socioeconomic sta-
tus was assigned to the collection district or residential postal
code of each patient using the Socioeconomic Indices for Areas
producedby theAustralianBureauof Statistics.35Collectiondis-
tricts, to which more than 80% of addresses in the study were
geocoded,wereused inpreference given that they are the small-
est geographical areausedby theAustralianBureauofStatistics.33
Therefore, they have greater validity thanpostal codes.36 Socio-
economic Indices forAreas gave a ranking to eachcollectiondis-
trict or postal code based on data collected in the 1996 census.
Proportional hazards regression was also used to examine
case fatality, adjusting for the same variables as incidence. In
this model, all patients (both psychiatric and nonpsychiatric)
who had a cancer diagnosed between January 1, 1988, and De-
cember 31, 2007, were included. Risk commenced at the date
of cancer diagnosis, and patients were censored at death or De-
cember 31, 2007. We used the same techniques to study time
to surgery, adjusting for the presence of metastases, as well as
patient demographic characteristics and clinical features.
In terms of access to other treatments, we used multiple re-
gression to study the effect of psychiatric status on the num-
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ber of chemotherapy sessions. We adjusted for the same vari-
ables as for access to surgery. Sensitivity analyses were carried
out of the effect of omitting cancers where chemotherapy was
least likely to be used (prostate, malignant melanoma, uter-
ine, thyroid, kidney, lip, gum, mouth, and brain cancers).
RESULTS
INCIDENCE
There were 135 442 new cases of cancer, of which 6586
occurred in people with mental illness. The psychiatric
patients who developed cancer had a mean (SD) age of
64.3 (17.7) years, comparedwith amean (SD) age of 63.2
(16.0) years among patients with cancer and no psychi-
atric history. Among the psychiatric patients, 3147
(47.8%)weremale. Psychiatric patients with cancer were
more likely to live in regional or rural areas and more
likely to live in areas in the bottom 20% of socioeco-
nomic status than the general population who devel-
oped cancer (Table 2). The age-standardized inci-
dence rate for cancer in psychiatric patients was 368 per
100000person-years comparedwith 417per 100000per-
son-years in the general population. This equated to an
RR of 0.88 (95% CI, 0.85-0.91). Overall cancer inci-
dence was lower for psychiatric patients than for the gen-
eral population in both males and females (Table 3).
In terms of specific sites, incidence in psychiatric pa-
tients was higher only for lung cancers in males and fe-
males as well as those of unknown primary site in males
(Table 3). At all other cancer sites, incidence was either
the same as in the general population or, in the case of
colorectal, melanoma, prostate, or breast cancers, lower
(Table 3).
In terms of specific psychiatric diagnoses, all-site can-
cer rates were elevated inmales with alcohol or drug dis-
orders (Table4) and bothmale and female patients with
other psychoses (ICD-9 codes 293, 294, 297-299)
(Table 4). Statistically significantly lower cancer inci-
dence rates were observed in males with affective psy-
choses, stress or adjustment reactions, and nonspecific
psychiatric diagnoses (Table 4).
On Cox regression, the risk of cancer was higher in
males than females (HR = 1.21; 95% CI, 1.16-1.28), and
cancer risk increased with age. We found no significant
association of cancer incidence with socioeconomic sta-
tus. Using nonspecific psychiatric diagnoses as the ref-
erence category, patients with dementia had a reduced
risk of cancer (HR = 0.72; 95%CI, 0.62-0.83), as did those
with schizophrenia (HR = 0.80; 95% CI, 0.67-0.95). By
contrast, patients with the following diagnoses had an
increased risk: depression (HR = 1.20; 95% CI, 1.05-
1.38), neurotic disorders (HR = 1.20; 95% CI, 1.04-
1.38), and alcohol or drug disorders (HR = 1.26; 95%CI,
1.08-1.46). Similarly, patients who had spent more than
3 months as an inpatient had a 20% lower risk of cancer
incidence comparedwith those treated as outpatients only
(HR = 0.79; 95% CI, 0.71-0.88).
MORTALITY
A total of 3056 psychiatric patients diagnosed as having
cancer died during the study period, of whom 1569
(51.3%) were male. All-cause mortality was elevated in
both males and females (Table 3 and Table 4). The same
patternwas seen for cancermortality (eTable, http://www
.jamapsych.com).
All-cause mortality was highest for melanoma, colo-
rectal cancers, and cancers of unknown primary site. For
males, rates were also particularly high for prostate, other
urological, and lung cancers; for females, rateswere higher
for gynecological and upper gastrointestinal tract can-
cers (Table 3). Cancer-specific mortality was high for gy-
necological (RR = 1.26; 95% CI, 1.01-1.58), prostate
(RR = 1.51; 95%CI, 1.25-1.83), and other male urologi-
cal (RR = 1.38; 95% CI, 1.06-1.80) cancers. Rates were
also high for melanoma (RR = 1.47; 95% CI, 1.01-2.14)
and colorectal cancer (RR = 1.54; 95% CI, 1.30-1.82) in
females and for those of unknown primary site in males
(RR = 1.49; 95% CI, 1.21-1.84).
By principal psychiatric diagnosis, patients with de-
mentia, an alcohol or drug disorder, schizophrenia, other
psychoses, and depression had the highest all-cause and
cancer mortality RRs (Table 4 and eTable).
On Cox regression, male sex, older age, and lower so-
cioeconomic status were associated with higher all-
cause mortality (Table 5). After adjusting for demo-
graphic factors, there was a 41% higher mortality rate
following cancer diagnosis (Figure1). The HRwas 1.20
(95% CI, 1.15-1.26) when restricted to cancer mortal-
ity. The results for individual sites were very similar to
those in the unadjusted analyses. The highest all-cause
mortality occurred in patients with schizophrenia
(HR = 1.96; 95% CI, 1.67-2.31) as well as those with an
alcohol or drug disorder (HR = 2.08; 95% CI, 1.85-
2.35), with a similar pattern for cancer mortality.
METASTASES
The proportion of patients with cancer who had metas-
tases at presentation was significantly higher in psychi-
atric patients (7.1%; 95%CI, 6.5%-7.8%) compared with
the general population (6.1%; 95% CI, 6.0%-6.2%). Of
specific cancer sites,more psychiatric patients with breast
Table 2. Place of Residence and Socioeconomic Status
of Patients With Cancer With and Without Contact
With Mental Health Services
Characteristic
Contact With Mental
Health Services
No. (%) Odds
Ratio
(95% CI)
Yes
(n = 6586)
No
(n = 128 865)
Residence in regional
or rural area
2043 (31.0) 31 771 (24.7) 1.38 (1.30-1.45)
Socioeconomic status,
quintile
Highest 882 (13.4) 21 145 (16.4) 1 [Reference]
Second highest 1112 (16.9) 24 601 (19.1) 1.25 (1.15-1.36)
Third 1206 (18.3) 25 036 (19.4) 1.16 (1.06-1.26)
Second lowest 1592 (24.2) 30 575 (23.7) 1.07 (0.99-1.19)
Lowest 1794 (27.2) 27 508 (21.3) 1.56 (1.44-1.70)
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cancer had metastases at presentation (6.3%; 95% CI,
5.9%-6.6%) than the general population (4.5%; 95% CI,
3.1%-5.9%). The same applied to lung cancer, with pro-
portions of 0.6% (95% CI, 0.5%-0.7%) and 0.2% (95%
CI, 0.0%-0.5%), respectively, but no other sites.
ACCESS TO SERVICES
We assessed time to surgery using Cox regression to cal-
culate HRs and adjust for demographic and clinical vari-
ables, including the presence of metastases at presenta-
Table 3. Cancer Incidence and All-Cause Mortality of Psychiatric Patients as Compared With the Rates of the Sex- and Age-Matched
General Population
Cancer Site
Cancer Incidence Mortality
No. Rate Ratio (95% CI) No. Rate Ratio (95% CI)
Males
Prostate 652 0.84 (0.76-0.92) 247 1.91 (1.68-2.18)
Colorectal 356 0.89 (0.78-0.99) 176 1.49 (1.28-1.74)
Malignant melanoma 285 0.72 (0.61-0.86) 77 1.93 (1.54-2.44)
Lung 406 1.11 (1.01-1.22) 296 1.24 (1.11-1.40)
Kidney, bladder, or urinary tract 191 0.95 (0.81-1.12) 98 1.59 (1.30-1.96)
Stomach, pancreatic, or esophageal 202 1.04 (0.90-1.19) 132 1.14 (0.96-1.36)
Unknown primary site 151 1.43 (1.27-1.61) 118 1.56 (1.30-1.89)
All cancersa 3147 0.86 (0.82-0.90) 1569 1.52 (1.45-1.60)
Females
Breast 903 0.92 (0.85-0.89) 225 1.27 (1.11-1.45)
Colorectal 362 0.82 (0.74-0.94) 200 1.61 (1.39-1.86)
Malignant melanoma 333 0.84 (0.73-0.96) 72 1.69 (1.32-2.16)
Lung 301 1.28 (1.17-1.41) 214 1.09 (0.95-1.26)
Uterine, ovarian, or cervical 296 0.91 (0.80-1.04) 118 1.42 (1.18-1.72)
Kidney, bladder, or urinary tract 110 1.15 (0.83-1.59) 54 0.91 (0.69-1.20)
Stomach, pancreatic, or esophageal 164 0.94 (0.78-1.13) 121 1.23 (1.03-1.48)
Unknown primary site 165 1.09 (0.93-1.28) 135 1.23 (1.03-1.47)
All cancersa 3439 0.92 (0.88-0.96) 1487 1.29 (1.22-1.36)
a Includes lower-incidence cancers not listed here.
Table 4. Cancer Incidence and All-Cause Mortality of Patients With Specific Psychiatric Disorders as Compared With the Rates
of the Sex- and Age-Matched General Population
Psychiatric Disorder
Incidence Mortality
No. Rate Ratio (95% CI) No. Rate Ratio (95% CI)
Male
Dementia 685 1.19 (0.85-1.68) 473 1.72 (1.57-1.89)
Alcohol or drug disorders 391 1.18 (1.06-1.31) 219 2.10 (1.84-2.40)
Schizophrenia 129 0.79 (0.61-1.02) 72 2.21 (1.75-2.78)
Affective psychosis 358 0.85 (0.75-0.98) 129 1.08 (0.91-1.28)
Other psychoses 302 1.14 (1.01-1.28) 165 1.75 (1.50-2.04)
Neurotic disorders 260 0.91 (0.79-1.06) 120 1.37 (1.14-1.63)
Personality disorders 35 0.74 (0.48-1.15) 14 1.69 (1.00-2.85)
Stress or adjustment reaction 267 0.79 (0.65-0.95) 83 0.95 (0.77-1.18)
Depressive disorder 423 1.04 (0.93-1.17) 204 1.48 (1.29-1.69)
Nonspecific diagnosis 102 0.54 (0.35-0.83) 30 0.96 (0.67-1.37)
Totala 3147 0.86 (0.82-0.90) 1569 1.52 (1.45-1.60)
Females
Dementia 714 0.84 (0.61-1.14) 539 1.41 (1.29-1.54)
Alcohol or drug disorders 123 1.16 (0.97-1.39) 55 1.91 (1.47-2.49)
Schizophrenia 146 0.97 (0.81-1.16) 75 1.77 (1.41-2.22)
Affective psychosis 459 0.91 (0.81-1.02) 132 1.08 (0.91-1.28)
Other psychoses 227 1.59 (1.29-1.97) 146 1.81 (1.54-2.14)
Neurotic disorders 419 0.96 (0.87-1.07) 147 1.08 (0.92-1.27)
Personality disorders 27 1.09 (0.73-1.65) 9 1.43 (0.74-2.75)
Stress or adjustment reaction 396 0.92 (0.79-1.06) 93 0.90 (0.73-1.10)
Depressive disorder 538 0.97 (0.88-1.07) 197 1.29 (1.12-1.48)
Nonspecific diagnosis 188 0.81 (0.65-1.02) 42 0.84 (0.62-1.14)
Totala 3439 0.92 (0.88-0.96) 1487 1.29 (1.22-1.36)
a Includes attempted self-harm and other mental disorders not listed here.
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tion.Psychiatricpatientshada reduced likelihoodof surgery
(HR = 0.81; 95%CI, 0.76-0.86) (Figure2).Males andolder
people were also less likely to have surgery. We found no
significant association with socioeconomic status, length
of inpatient stay, or type of care received.
Of specific cancer sites, males were less likely to have
a colorectal resection (HR = 0.82; 95%CI, 0.70-0.97). Fe-
males were less likely to have surgery for colorectal
(HR = 0.68; 95%CI, 0.57-0.81), breast (HR = 0.74; 95%
CI, 0.67-0.82), and cervical (HR = 0.73; 95% CI, 0.53-
0.99) cancers. Resection rateswere lowest in patientswith
dementia (HR = 0.70; 95% CI, 0.60-0.82), affective psy-
choses (HR = 0.78; 95% CI, 0.66-0.98), other psychoses
(HR = 0.75; 95% CI, 0.58-0.98), and depression
(HR = 0.75; 95% CI, 0.65-0.87).
Psychiatric patients also received significantly fewer
chemotherapy sessions (mean, 10.3 sessions; 95% CI,
9.1-11.4) than the general population (mean, 12.1 ses-
sions; 95% CI, 11.6-12.7). On multiple regression, the
average number of sessions in psychiatric patients was
reduced by 2.0 (95% CI, 1.2-2.9), with the same
results when restricted to cancers for which chemo-
therapy was most likely to be used (mean, 2.0 ses-
sions; 95% CI, 1.1-2.8).
There was no difference in the proportion receiving
radiotherapy between psychiatric patients (6.4%; 95%CI,
5.8%-7.0%) and the general population (6.6%; 95% CI,
6.5%-6.8%). However, they were less likely to receive ra-
diotherapy for breast (psychiatric patients: 2.6%; 95%CI,
1.5%-3.7%; general population: 4.1%; 95% CI, 3.8%-
4.4%), colorectal (psychiatric patients: 1.6%; 95% CI,
0.6%-2.6%; general population: 3.9%; 95% CI 3.6%-
4.2%), and uterine (psychiatric patients: 13.0%; 95%CI,
5.5%-20.0%; general population: 21.1%; 95%CI, 20.0%-
22.9%) cancers (all P  .05).
We found no difference in our results when using in-
direct as opposed to direct standardization. For in-
stance, the indirectly standardized incidence rates for all
cancers were 0.84 (95%CI, 0.80-0.88) inmales and 0.88
(95% CI, 0.84-0.92) in females.
COMMENT
This study suggests that although the cancer incidence
in psychiatric patients is no higher than in the general
population, psychiatric patients are more likely to have
metastases at diagnosis and less likely to receive special-
ized interventions. This may explain the greater case fa-
tality found in peoplewith psychiatric disorder. The simi-
larity in results betweendirect and indirect standardization
confirmed that the cohort size was sufficient to under-
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Figure 1. Survival since diagnosis of all cancers by contact with mental
health services. WA indicates Western Australia.
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Figure 2. Time from diagnosis to surgical removal of the tumor by contact
with mental health services. WA indicates Western Australia.
Table 5. Proportional Hazards Regression
of All-Cause Mortalitya
Characteristic
Hazard Ratio
(95% CI)
Male 1.19 (1.17-1.20)
Age, y
0-49 1 [Reference]
50-59 1.81 (1.74-1.87)
60-69 2.68 (2.60-2.77)
70-79 4.49 (4.36-4.65)
80 8.01 (7.76-8.27)
Residence in regional or rural area 0.98 (0.96-1.00)
Socioeconomic status, quintile
Highest 1 [Reference]
Second highest 1.11 (1.08-1.14)
Third 1.23 (1.20-1.27)
Second lowest 1.28 (1.24-1.31)
Lowest 1.48 (1.40-1.52)
Contact with mental health services
as inpatient or outpatient
1.41 (1.36-1.46)b
Cancer had metastasized at time of diagnosis 1.59 (1.55-1.64)
Length of inpatient treatmentc
No contact with mental health services 1 [Reference]
Outpatient only 1.22 (1.13-1.31)
1 wk 1.42 (1.32-1.53)
1-4 wk 1.52 (1.42-1.63)
2-3 mo 1.53 (1.40-1.67)
3 mo 1.44 (1.29-1.61)
aThe proportional hazards regression adjusts for age, sex, socioeconomic
status, cancer incidence, and contact with mental health services.
bThe model restricted to cancer mortality gives a hazard ratio of 1.20
(95% CI, 1.15-1.26).
cReran as a separate model with length of inpatient treatment replacing
contact with mental health services.
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take direct standardization and that the results were ro-
bust to the choice of method.
One explanation is that cancer goes unrecognized es-
pecially among those with severe mental illness, al-
though this may apply less to cancer than other physical
diseases.4,37-39 For instance, postmortem data from Den-
mark, where autopsies are common, indicate that post-
mortem diagnoses of previously unrecognized cancer in
people with schizophrenia were rare.39
Another explanation is that people with psychiatric
disorder receive poorer care. While there is little infor-
mation on cancer care for psychiatric patients, there is
extensive research on inequities in treatment access for
cardiovascular disease anddiabetes from theUnited States,
Canada, Australia, and Great Britain.10,16,22,40-46 For in-
stance, psychiatric patients are less likely to have their
weight or blood pressure measured in primary care40 or
to be assessed or treated for hyperlipidemia.41,42 This is
despite physician consultation rates being generally high
among those with severe mental illness.43 Management
of physical health in secondary health services may be
no better. Psychiatric patients are less likely to receive
specialist procedures such as cardiac catheterizations and
coronary artery bypass grafting than the general popu-
lation, even though theirmortality rates for the same con-
ditions are significantly higher.10,16 On discharge from the
hospital followingmyocardial infarction, they are also less
likely to be prescribed -blockers and statins.44 In some
cases, unequal access to health care seems to explainmuch
of the subsequent excess mortality.45 Although it is pos-
sible that physicians are reluctant to offer some proce-
dures because of the ensuing psychological stress, con-
cerns about capacity or compliance with postoperative
care, or contraindications such as smoking, this would
not explain disparities in the prescription of cardiovas-
cular medications.44,46
This study extends our previous work, indicating that
psychiatric patients are no less likely to develop cancer
than the general population but are more likely to die of
it.14,17 This pattern was particularly evident for colorec-
tal, melanoma, prostate, and breast cancers. It is there-
fore unlikely that the increased mortality rate from can-
cer can solely be explained by lifestyle, such as alcohol
or tobacco use. If lifestyle were the only cause, cancer
incidence should be similarly increased. Furthermore,
concurrent lifestyle would not explain our findings for
melanoma. This is mainly related to childhood sun ex-
posure,47 and there is no evidence of any difference in
such exposure in individuals who subsequently de-
veloppsychiatric disorder.39 These findings applied to both
cancer and all-cause mortality rates. The fact that all-
cause mortality was higher than cancer mortality high-
lights that patients with cancer often have medical co-
morbidities and that the direct cause of death may be
another illness to which cancer made them susceptible.
In common with some other studies, we found a re-
duced adjusted incidence of cancer in patients with de-
mentia and schizophrenia.48-50 Biological theories for re-
duced incidence in schizophrenia include aprotective effect
of excess dopamine, enhanced natural killer cell activity,
increased apoptosis,modulation by antipsychotic drugs of
cytochrome enzymes involved in mutagen activation and
elimination, and neonatal vitamin D deficiency.49-51 Some
of these may be underpinned by genes that predispose to
schizophrenia but protect against cancers, because rela-
tives of people with schizophrenia also have reduced can-
cer incidence.39,51 However, we also found a lower cancer
incidence for patientswith psychiatric disorders other than
schizophrenia, making it unlikely that biological theories
can be the only explanation.
Our results also cannot be solely explained by more
advanced disease on presentation as marked by metas-
tases. Although there was a modest increase in the pro-
portion of patients withmetastases for cancer overall, this
did not apply tomajor cancer sites such as colorectal and
prostate cancers where the disparities between inci-
dence and mortality were the greatest.
These results could suggest inequitable access to ap-
propriate care, especially given that reduced access to treat-
ment persisted after controlling for the presence of me-
tastases. The results may indicate action required to
decrease inequity and thus improve health outcomes of
psychiatric patients. This would include a greater em-
phasis on earlier diagnosis and better access to cancer
screening for sites such as colorectal, prostate, and breast
cancers. Another might be guidelines for cancer screen-
ing and treatment for psychiatric patients similar to those
for cardiovascular and diabetes care.52 Given findings that
72% of excess deaths occur in patients who have only
ever seen their family doctor for their psychiatric prob-
lems,11 collaborative arrangementswith primary caremay
be helpful.53
LIMITATIONS
Ethnicity, marital status, education level, comorbidity,
and disability are not recorded on the cancer registry
and so could not be included in our models. However,
the consistent results for all-cause and cancer mortality
may suggest that comorbidity was not a major issue in
this study. There was also no information on medica-
tion. Although we adjusted for socioeconomic status,
our results may not be generalizable to people who
receive private psychiatric treatment, especially outpa-
tients. In addition, socioeconomic status was assigned by
residential collection district or postal code rather than
individual-level information. The WA Cancer Registry
does not contain information on staging other than the
presence or absence of metastases. Administrative data
may also be subject to recording bias, especially for diag-
nosis and particularly in secondary fields. We therefore
emphasized overall psychiatric morbidity, not subcat-
egories or secondary diagnoses, to minimize possible
bias. We were unable to study the effects of lifestyle
such as diet, smoking, or alcohol and substance use.
However, it is unclear how lifestyle differences could be
the sole explanation for increased mortality in the pres-
ence of an incidence that was no higher than that of the
general population. Although lifestyle might affect or be
a contraindication for some cancer interventions, the
documented disparities in cardiovascular treatments
with no such contraindications suggest that this might
not be the only explanation.22,42,44,46,52 There were small
cell sizes for certain cancers and psychiatric diagnoses,
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so the study may have been underpowered to detect
some differences in, for example, the presence of metas-
tases or treatment access for individual cancer sites. In
addition, we were able to capture data only on hospital
admissions for surgery, radiotherapy, or chemotherapy.
We cannot comment on access to other interventions or
other private facilities. In the case of the latter, though,
we are more likely to have underestimated the difference
between psychiatric patients and the general population
given the barriers that the former face in affording pri-
vate treatment.54 Finally, we cannot be sure of the gener-
alizability of our findings. However, given the known
international disparities in cardiovascular and diabetes
care,22,42,44,46,52 it is certainly possible that the same might
apply to cancer.
IMPLICATIONS
Although the presence of metastases was no higher for
prostate, cervical, or colorectal cancers, for which
screening is available, this does not mean that
increased screening for people with psychiatric disor-
ders would not improve outcome. First, the presence
of metastases at presentation is a crude indicator of
cancer stage. Further work is indicated using cancer
registry data with more details on staging than are
available in the WA Cancer Registry. Second, the
uptake of screening may be less important than what
happens subsequently. Having identified a suspicious
result, how is the information used to ensure that psy-
chiatric patients receive the appropriate intervention?
Another area for research is access to treatments that
do not require hospital admission, such as tamoxifen
citrate.
In terms of clinical practice, this study suggests that
psychiatric patients experience similar difficulties with
access to cancer care as for cardiovascular care. This may
contribute to higher case fatality rates in illnesses forwhich
the incidence is no higher than that of the general
population.
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